Search - tctmd.com

Displaying 401 - 420 of 3533

Sort: Relevancy | Date

Podcast TCTMD Talking Points

The COMPLETE Trial

July 05, 2023

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

Caitlin E. Cox

June 26, 2023

Presentation Complex Coronary Cases 2023

Achieving STEMI Quality Recognition Through Process Improvement

Presenter: Andriy Vengrenyuk

June 16, 2023

Presentation Complex Coronary Cases 2023

Practical Application of New BifurcAID, STEMIcathAID, and MCSAID Apps

Presenter: Annapoorna S. Kini

June 16, 2023

Presentation Complex Coronary Cases 2023

STEMI and MCS

Presenter: Gregory Serrao

June 14, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Conference News EuroPCR 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Caitlin E. Cox

May 24, 2023

News Conference News EuroPCR 2023

Many ACS Patients With Occlusions Are Falling Through the Cracks

Todd Neale

May 19, 2023

News Daily News

To Boost Access and Outcomes With New PCI Centers, Location Matters

L.A. McKeown

May 08, 2023

News Daily News

Hospitals That Set STEMI Standards Can Better Serve Black Patients

Caitlin E. Cox

April 25, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Daily News

Around the World, Finances Impact Acute MI Outcomes in Older Adults

Caitlin E. Cox

April 04, 2023

Presentation THT 2023

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

Presenter: Tyler Bonkowski

March 21, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Impact of ST Elevation Myocardial Infarction (STEMI) on patients with chronic heart failure: A National Analysis

Presenter: Dhairya Nanavaty

March 20, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

Advertisement

The COMPLETE Trial

Wintertime Brings Increased IHCA Risk, US Data Show

Achieving STEMI Quality Recognition Through Process Improvement

Practical Application of New BifurcAID, STEMIcathAID, and MCSAID Apps

STEMI and MCS

CABG and PCI Comparable in ACS Patients With Left Main CAD

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Many ACS Patients With Occlusions Are Falling Through the Cracks

To Boost Access and Outcomes With New PCI Centers, Location Matters

Hospitals That Set STEMI Standards Can Better Serve Black Patients

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Around the World, Finances Impact Acute MI Outcomes in Older Adults

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Impact of ST Elevation Myocardial Infarction (STEMI) on patients with chronic heart failure: A National Analysis

March 2023 News Roundup

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content